23. Oktober 2016 | Hepatitiden
Efficacy and safety of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic HCV genotype 1 infection receiving opioid substitution therapy: Analysis of Phase 3 ION trials
Grebely J, Mauss S, Brown A, Bronowicki JP, Puoti M, Wyles D, Natha M, Zhu Y, Yang J, Kreter B, Brainard DM, Yun C, Carr V, Dore GJ.; Clin Infect Dis. 2016 Aug 23. pii: ciw580. [Epub ahead of print]
Abstract
http://www.ncbi.nlm.nih.gov/pubmed…
